BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 27, 2024
See today's BioWorld
Home
» Ziopharm Nabs Asian Partner for PTCL Drug Darinaparsin
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Ziopharm Nabs Asian Partner for PTCL Drug Darinaparsin
March 8, 2011
By
Jennifer Boggs
No Comments
Ziopharm Oncology Inc. inked its first partnership for organic arsenic drug darinaparsin, signing a regional deal with Tokyo-based Solasia Pharma K.K. focused on specific Pan-Asian/Pacific territories.
BioWorld